JAG2 and esophageal squamous cell carcinoma: The expression levels of both JAG1 and JAG2 were significantly lower at the inflammatory and neoplastic stages, which represent the early stages of ESCC carcinogenesis, compared to the normal state (Fig. 9a, b).